Bremelanotide
Melanocortin Receptor Agonist — Research Grade (PT-141)
"A melanocortin receptor agonist for CNS and neuroendocrine pathway research."
Bremelanotide (PT-141) is a melanocortin receptor agonist peptide supplied for in vitro and laboratory research use only. Researchers use it to study melanocortin receptor subtypes (MC1R, MC4R), central nervous system neuroendocrine signaling, and melanocortin pathway pharmacology in controlled experimental models. Not for human or veterinary use.
Contact our research team to discuss purity specifications, available quantities, certificate of analysis, and shipping requirements for your laboratory.
For in vitro laboratory research use only. Not for human or veterinary consumption. A Certificate of Analysis (CoA) is provided with every order.
How It Works
In laboratory research settings, bremelanotide activates melanocortin receptor subtypes, enabling researchers to study MC1R and MC4R binding kinetics, downstream CNS signaling cascades, and the pharmacology of the melanocortin system. It is a valuable tool for neuroendocrine receptor research and melanocortin pathway biology.
Observed Research Endpoints
- Enables MC1R and MC4R receptor binding and activation studies
- Supports CNS neuroendocrine signaling pathway research
- Valuable tool for melanocortin system pharmacology
- Well-characterized peptide with extensive research literature
- Suitable for receptor binding assays and cell-based studies
Important Considerations
- For laboratory research use only — not for human or veterinary consumption
- Handle according to institutional biosafety protocols
- Store under recommended conditions to maintain peptide integrity
- Requires qualified research personnel and appropriate laboratory facilities
- Dispose of in accordance with institutional waste management guidelines
Supplied as a research-grade peptide for in vitro laboratory use only. Not intended or suitable for administration to humans or animals. All research must comply with applicable institutional and regulatory requirements.